subimg02
Home  >> Transactions>> AHN biotechnologie has been sold to Capp

AHN biotechnologie has been sold to Capp

HBIO - AHN - CAPP

Harvard Bioscience, Inc. (Nasdaq: HBIO) has sold its subsidiary, AHN Biotechnologie GmbH, to Capp ApS. Based in Nordhausen, Germany, AHN Biotechnologie specializes in the development, manufacturing and distribution of liquid handling products for the use in laboratories worldwide.

Others

Nova Instruments Acquires Stresstech Oy      Learn More >>
Spartaco acquires Tiiger      Learn More >>
Union Park Capital acquires Systech Illinois      Learn More >>
Xylem has sold PCI Membranes to Madison Industries      Learn More >>
In-Situ acquires MACE      Learn More >>
KSB has sold AMRI to Bray      Learn More >>
Nova Instruments Acquires Degree Controls Inc.      Learn More >>
Suez has sold Ameriwater to Empire IH      Learn More >>
Repligen has acquired TangenX      Learn More >>
Biolin Scientific divests Analytical Instruments to AddLife      Learn More >>
AHN biotechnologie has been sold to Capp      Learn More >>
TestAmerica has been acquired by JSTI Group      Learn More >>